Innovation Pharmaceuticals Inc (IPIX)

[F1ash]

Excellent points.
One of the factors which gives me the most confidence is the previous trial and accompanying research were performed by an entirely different company and group of researchers. Since the 2b results ( by a different company in a different country even) are so similar, the odds that the results are reliable is increased.

I can say, for instance, that Brilacidin will probably not be a good choice for bladder infections. How many of our traders have a clue why that is the case?